BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CMS QIN-QIO - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CMS QIN-QIO
X-ORIGINAL-URL:https://qi.ipro.org
X-WR-CALDESC:Events for CMS QIN-QIO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T120000
DTEND;TZID=America/New_York:20220602T123000
DTSTAMP:20260418T131955
CREATED:20220414T205248Z
LAST-MODIFIED:20220414T205248Z
UID:33424-1654171200-1654173000@qi.ipro.org
SUMMARY:Small Talks: Caring for Residents with Chronic Kidney Disease
DESCRIPTION:The Centers for Disease Control and Prevention estimates 37 million Americans are living with chronic kidney disease (CKD). With numbers steadily increasing more patients with CKD are residing or visiting a nursing home for a short-term stay. CKD patients are medically complex\, often requiring care for multiple comorbidities. \nEmphasizing the unique needs of these patients can slow the progression of CKD\, ensure adequate care\, and quality of life. This session will discuss the health challenges of CKD patients\, the stages and progression into end-stage renal disease (ESRD)\, and important nutrition\, medication\, and medical management necessary for well-rounded care. \nLearning Objectives: \n\nIdentify at least three unique elements of caring for a patient with chronic kidney disease\nDefine the levels of chronic kidney disease and the progression to end-stage renal disease\nSummarize the importance of diet/nutrition\, medication management\, and management of comorbid conditions as they relate to chronic kidney disease\nIntegrate knowledge gained into practice when caring for chronic kidney disease patients
URL:https://qi.ipro.org/upcoming-events/small-talks-caring-for-residents-with-chronic-kidney-disease/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T120000
DTEND;TZID=America/New_York:20220608T123000
DTSTAMP:20260418T131955
CREATED:20220414T205611Z
LAST-MODIFIED:20220414T205611Z
UID:33426-1654689600-1654691400@qi.ipro.org
SUMMARY:Small Talks: Caring for Residents with Chronic Kidney Disease
DESCRIPTION:The Centers for Disease Control and Prevention estimates 37 million Americans are living with chronic kidney disease (CKD). With numbers steadily increasing more patients with CKD are residing or visiting a nursing home for a short-term stay. CKD patients are medically complex\, often requiring care for multiple comorbidities. \nEmphasizing the unique needs of these patients can slow the progression of CKD\, ensure adequate care\, and quality of life. This session will discuss the health challenges of CKD patients\, the stages and progression into end-stage renal disease (ESRD)\, and important nutrition\, medication\, and medical management necessary for well-rounded care. \nLearning Objectives: \n\nIdentify at least three unique elements of caring for a patient with chronic kidney disease\nDefine the levels of chronic kidney disease and the progression to end-stage renal disease\nSummarize the importance of diet/nutrition\, medication management\, and management of comorbid conditions as they relate to chronic kidney disease\nIntegrate knowledge gained into practice when caring for chronic kidney disease patients
URL:https://qi.ipro.org/upcoming-events/small-talks-caring-for-residents-with-chronic-kidney-disease-2/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220616T120000
DTEND;TZID=America/New_York:20220616T120000
DTSTAMP:20260418T131955
CREATED:20220510T205538Z
LAST-MODIFIED:20220609T155451Z
UID:33566-1655380800-1655380800@qi.ipro.org
SUMMARY:Small Talks: HEOA Knowledge Builders Series\, Category I: Data Collection
DESCRIPTION:In this session\, we’ll discuss best practices for implementing a standardized procedure for collecting patient self-reported race\, ethnicity\, and language (REaL) data\, and additional demographic data such as SO/GI\, disability status\, and social determinants of health factors. \n\nUnderstand why accurate collection of patient demographic data is critical for identifying and addressing health disparities.\nDescribe best practices for implementing a system-wide\, standardized process for accurate collection of patient self-reported REaL and other demographic data.\nShare helpful resources.
URL:https://qi.ipro.org/upcoming-events/small-talks-health-equity-organizational-assessment-heoa-category-i-data-collection/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220622T120000
DTEND;TZID=America/New_York:20220622T123000
DTSTAMP:20260418T131955
CREATED:20220608T181732Z
LAST-MODIFIED:20220608T181822Z
UID:33803-1655899200-1655901000@qi.ipro.org
SUMMARY:Small Talk: Ambulatory Care COVID-19 Antivirals (Paxlovid\, Lagevrio): Overview for Healthcare Professionals
DESCRIPTION:A presentation highlighting the two available oral treatment options for mild to moderate COVID-19 in the ambulatory care setting. \nObjectives: \n\nReview the IDSA guidelines for treatment of mild to moderate COVID-19 infection in the ambulatory care setting\nExplore the difference between FDA approval and Emergency Use Authorization\nDescribe the dosing\, side effects and drug interactions associated with Paxlovid and Lagevrio\nSummarize the published COVID-19 efficacy data for Paxlovid and Lagevrio
URL:https://qi.ipro.org/upcoming-events/small-talk-ambulatory-care-covid-19-antivirals-paxlovid-lagevrio-overview-for-healthcare-professionals/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T120000
DTEND;TZID=America/New_York:20220623T120000
DTSTAMP:20260418T131955
CREATED:20220511T144446Z
LAST-MODIFIED:20220609T155427Z
UID:33606-1655985600-1655985600@qi.ipro.org
SUMMARY:Small Talks: HEOA Knowledge Builders Series\, Category II: Data Collection Training
DESCRIPTION:In this session\, we’ll discuss best practices for training your workforce on how to collect accurate\, patient self-reported demographic data in a way that increases patient comfort and staff confidence. \n\nShare different options and best practices for training staff on the accurate collection of patient self-reported REaL and other demographic data.\nUnderstand how to evaluate the effectiveness of workforce training to ensure staff demonstrate competency.\nShare helpful resources.
URL:https://qi.ipro.org/upcoming-events/small-talks-health-equity-organizational-assessment-heoa-category-ii-data-collection-training/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T120000
DTEND;TZID=America/New_York:20220623T123000
DTSTAMP:20260418T131955
CREATED:20220322T211821Z
LAST-MODIFIED:20220323T231101Z
UID:33311-1655985600-1655987400@qi.ipro.org
SUMMARY:Check in with the QIO - Office Hours
DESCRIPTION:A monthly half-hour zoom session to follow up on recent Small Talks\, explore new intervention(s)\, ask questions\, and connect with peers. \nThese 30-minute sessions do not require registration.
URL:https://qi.ipro.org/upcoming-events/check-in-with-the-qio-office-hours-4/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220630T120000
DTEND;TZID=America/New_York:20220630T120000
DTSTAMP:20260418T131955
CREATED:20220511T151104Z
LAST-MODIFIED:20220609T155327Z
UID:33618-1656590400-1656590400@qi.ipro.org
SUMMARY:Small Talks: HEOA Knowledge Builders Series\, Category III: Data Validation
DESCRIPTION:In this session\, we’ll discuss how to implement a standardized process to evaluate the accuracy and completeness of self-reported patient REaL and other demographic data. \n\nShare best practices for implementing a system-wide\, standardized process for data validation.\nUnderstand to evaluate and address system level issues throughout evaluation processes to continually improve the collection of patient demographic data.\nShare helpful resources.
URL:https://qi.ipro.org/upcoming-events/small-talks-heoa-knowledge-builders-series-category-iii-data-validation/
LOCATION:Online via Zoom
END:VEVENT
END:VCALENDAR